A £225 million supercomputer is pioneering the use of artificial intelligence (AI) to develop new drugs and vaccines.
Once fully operational this summer, the Isambard-AI, based in Bristol, will rank as the UK’s most powerful supercomputer. Globally, it will be among the top 10 fastest supercomputers, housed at the National Composites Centre in Emersons Green.
Enhancing Drug and Vaccine Development
Prime Minister Sir Keir Starmer recently announced plans to “unleash AI” across the UK, aiming to drive innovation and growth. Simon McIntosh-Smith, a professor at Bristol University, highlighted the groundbreaking potential of Isambard-AI. “The UK can genuinely compete on the world stage,” he said.
Currently, part of the system is operational. Researchers are already leveraging its capabilities to develop treatments for diseases like Alzheimer’s, heart disease, emphysema, and various cancers. Teams are also working to improve melanoma detection across diverse skin tones.
The supercomputer offers unmatched computational power, handling tasks previously impossible for humans. It excels in simulating how drugs interact with the body, down to the atomic level, enabling researchers to test millions of drug candidates virtually.
AI revolutionizes this process by focusing on promising drug interactions. Unlike traditional methods, which rely on educated guesses and physical testing, AI explores millions of potential combinations efficiently. According to Prof McIntosh-Smith, this innovation could save millions of lives by expediting drug development.
A Broader Impact on Society
In his speech, the prime minister emphasized AI’s vast potential, citing its use in diagnosing diseases and maintaining infrastructure like roads. Prof McIntosh-Smith compared the development of AI to transformative technologies like the internet or mobile phones. He noted that government funding ensures the research benefits the public rather than being confined to private enterprises.
Despite its efficiency-focused design, Isambard-AI requires significant energy. However, the supercomputer’s heat output presents a unique opportunity. Prof McIntosh-Smith explained, “We’re exploring ways to use waste energy to heat local homes and businesses.”
This pioneering initiative not only advances healthcare but also explores sustainable energy solutions. “We could be saving millions of lives,” Prof McIntosh-Smith remarked. “It’s brilliant to be doing this right here in Bristol.”
